Search form

NeuroLaunch, the first major worldwide program for neuroscience technology businesses, is taking Atlanta by storm in a rolling 90-day program aimed to give participants and their companies the tools needed to succeed, including seed funding, mentorship, and other resources, such as access to top research centers.

“We believe that technological solutions are going to play a large role in treating patients,” NeuroLaunch co-founder and Emory University Neurosurgery resident Jordan Amadio, MD, said in this FOX News report. “But these technologies need to come to market. They can’t remain as ideas in the laboratory without being translated.”

A fall 2014 cohort of start-ups were chosen Oct. 1. Applications are currently being taken for another cohort that will be chosen at an unspecified time for the summer 2015 program.